HARYANA GOVT. AND SAMSUNG INDIA SIGN A PACT

Samsung india and Haryana govt. signed a MOU to provide high tech equipment worth about Rs 1.25 crore to citizen hospital GURGAON.
Samsung India under its corporate social responsibility(CSR)has come voluntarily to donate modern hi-tech equipments to Citizen Hospital,GURGAON Dy.Commissioner T L Satyaprakash told reporters atGURGAON.

He further told’ the large no.of patients at our govt.run hospitals,we welcome such initiatives from companies like SAMSUNG in helping hospitals cater to the locals’need for quality health care’he said.

SAMSUNG INDIA vice president Rajiv Mishra said that Samsung has already started healthcare initiatives in CHENNAI ,MUMBAI and BANGLORE and very soon it is planing to start its 5th initiatives in national capitalDELHI.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices